---
figid: PMC2583357__nihms-77201-f0003
figlink: /pmc/articles/PMC2583357/figure/F3/
number: F3
caption: Amplification of HER2 is observed in 25 to 30% of breast cancer patients
  which can result in activation of both the PI3K/PTEN/Akt/mTOR and Raf/MEK/ERK cascades.
  Ras is mutated in approximately 35% of human cancers. B-Raf and Raf-1 are also mutated
  in certain human cancers. The PI3K/PTEN/Akt/mTOR pathway is also activated in breast
  cancer due to mutations at PI3K, PTEN and Akt as well as mutations at upstream receptors.
  Abnormal Akt activation is associated with a poorer prognosis for breast cancer
  and resistance to chemo-hormonal therapy.
pmcid: PMC2583357
papertitle: ALTERATION OF AKT ACTIVITY INCREASES CHEMOTHERAPEUTIC DRUG AND HORMONAL
  RESISTANCE IN BREAST CANCER YET CONFERS AN ACHILLES HEEL BY SENSITIZATION TO TARGETED
  THERAPY.
reftext: James A. McCubrey, et al. Adv Enzyme Regul. ;48:113-135.
pmc_ranked_result_index: '22501'
pathway_score: 0.9190312
filename: nihms-77201-f0003.jpg
figtitle: ALTERATION OF AKT ACTIVITY INCREASES CHEMOTHERAPEUTIC DRUG AND HORMONAL
  RESISTANCE IN BREAST CANCER YET CONFERS AN ACHILLES HEEL BY SENSITIZATION TO TARGETED
  THERAPY
year: ''
organisms:
- Homo sapiens
ndex: 265aeade-df0e-11ea-99da-0ac135e8bacf
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC2583357__nihms-77201-f0003.html
  '@type': Dataset
  description: Amplification of HER2 is observed in 25 to 30% of breast cancer patients
    which can result in activation of both the PI3K/PTEN/Akt/mTOR and Raf/MEK/ERK
    cascades. Ras is mutated in approximately 35% of human cancers. B-Raf and Raf-1
    are also mutated in certain human cancers. The PI3K/PTEN/Akt/mTOR pathway is also
    activated in breast cancer due to mutations at PI3K, PTEN and Akt as well as mutations
    at upstream receptors. Abnormal Akt activation is associated with a poorer prognosis
    for breast cancer and resistance to chemo-hormonal therapy.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - BRAF
  - RAF1
  - MAPK3
  - HRAS
  - MAPK1
  - CS
  - ARAF
  - AKT3
  - MAP2K1
  - AKT2
  - KRAS
  - ERBB2
  - PIK3R5
  - PIK3R4
  - PIK3CD
  - PTEN
  - PIK3R3
  - PIK3R6
  - AKT1
  - PIK3CG
  - PIK3CB
  - TSC2
  - PIK3CA
  - NRAS
  - MAP2K2
  - TSC1
  - Cancer
  - Cardiomyopathy
  - Lung cancer
  - Noonan syndrome
genes:
- word: Raf
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: BRAF
  entrez: '673'
- word: Raf
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: RAF1
  entrez: '5894'
- word: ERK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: Ras
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: HRAS
  entrez: '3265'
- word: ERK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: CS
  symbol: CS
  source: hgnc_symbol
  hgnc_symbol: CS
  entrez: '1431'
- word: Raf
  symbol: RAF
  source: bioentities_symbol
  hgnc_symbol: ARAF
  entrez: '369'
- word: Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: MEK
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K1
  entrez: '5604'
- word: Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: Ras
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: KRAS
  entrez: '3845'
- word: HER2
  symbol: HER-2
  source: hgnc_alias_symbol
  hgnc_symbol: ERBB2
  entrez: '2064'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R5
  entrez: '23533'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R4
  entrez: '30849'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CD
  entrez: '5293'
- word: PTEN
  symbol: PTEN
  source: hgnc_symbol
  hgnc_symbol: PTEN
  entrez: '5728'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R3
  entrez: '8503'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R6
  entrez: '146850'
- word: Akt
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CG
  entrez: '5294'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CB
  entrez: '5291'
- word: TSC1/2
  symbol: TSC2
  source: hgnc_symbol
  hgnc_symbol: TSC2
  entrez: '7249'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CA
  entrez: '5290'
- word: Ras
  symbol: RAS
  source: bioentities_symbol
  hgnc_symbol: NRAS
  entrez: '4893'
- word: MEK
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K2
  entrez: '5605'
- word: TSC1/2
  symbol: TSC1
  source: hgnc_symbol
  hgnc_symbol: TSC1
  entrez: '7248'
chemicals: []
diseases:
- word: Cancer
  source: ''
  identifier: ''
- word: Cardiomyopathy
  source: ''
  identifier: ''
- word: Lung cancer
  source: ''
  identifier: ''
- word: Noonan syndrome
  source: ''
  identifier: ''
figid_alias: PMC2583357__F3
redirect_from: /figures/PMC2583357__F3
figtype: Figure
---
